NasdaqGS:INSMBiotechs
Is It Too Late To Consider Insmed (INSM) After Its 85% One-Year Surge?
Wondering whether Insmed at around US$144.60 a share looks expensive or still has room to run? This breakdown will help you connect the recent share price with what the business might be worth.
The stock has seen very different return patterns, with a 1% gain over the last week, a 2.8% decline over the last month, an 18.4% decline year to date, an 85.9% return over the past year, and a very large gain over three years that is roughly 7x.
Recent coverage has focused on Insmed's position in...